Scientific and Technological Institutions (Instituições Científicas e Tecnológicas,
ICTs), such as Universities and Research Institutes, are undoubtedly
fundamental for the production and advancement of scientific and technological
knowledge; therefore, any sophisticated economic system in the world
increasingly depends on the exchange of knowledge between ICTs and
companies.
The process of developing new products goes through a series of risks inherent
to innovative processes. With that in mind, there has been an increasing
stimulus for interaction between the public and private sectors so that critical
stages of the new product development process can be developed by
companies in partnership with public institutions such as ICTs, which are better
equipped in terms of infrastructure and know-how, and can minimize both time
of development and resources invested.
In Brazil, health R&D has focused mainly in the public sector, in institutes of
excellence such as Butantan, linked to the São Paulo State Department of
Health and internationally considered as one of the largest centers of
biomedical research and main public producer of vaccines, antivenoms and
antitoxins in Latin America.
The Innovation Directorate is responsible for the policy for integral development
of new products, from the discovery of targets to their pilot production. It is
prepared to conduct the transfer of scientific and technological knowledge
developed by various research centers, both for the institution's production
complex and for companies interested in developing and commercially
exploring such technology, whether through new products, processes or
application in materials and/or services in health care.
The Innovation Directorate works by synchronizing the integrated efforts of
various units of the Institution.
Information
(+55 11) 2627-9700
cdi@butantan.gov.br
https://cdi.butantan.gov.br/